News 06 Jan 2022 Daxor Corporation to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference admin
News 05 Jan 2022 Daxor Announces Key Milestones Achieved for Multicenter BVA-100® Study in Hospitalized Patients With COVID-19 admin
News 04 Jan 2022 Daxor Awarded New Patent for Blood Volume Guidance Technology to Improve Treatment & Outcomes admin
News 16 Nov 2021 Daxor Corporation Presents New Data Validating the Benefit of the BVA-100® Blood Test for Optimal Heart Failure Management at Key Scientific Society Meeting admin
News 09 Nov 2021 New Research Demonstrates Clinical Utility of Daxor Corporation Blood Volume (BVA-100®) Diagnostic in Neurocritical Care admin
News 14 Sep 2021 Daxor Corporation Presents New Data Validating the Benefit of the BVA-100® Blood Test for Heart Failure Patients at Key Scientific Society Meeting admin
News 08 Sep 2021 Daxor Corporation To Present Compelling New Data and Clinical Trials Utilizing the BVA-100® Blood Test at the Heart Failure Society of America Annual Scientific Meeting 2021 admin
